Description: Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Home Page: www.akiliinteractive.com
AKLI Technical Analysis
No. 312, 71 Commercial Street
Boston,
MA
02109
United States
Phone:
617 313 8853
Officers
| Name | Title |
|---|---|
| Dr. Walter Edward Martucci II, Ph.D. | Co-Founder & Chairman |
| Mr. Matthew Franklin M.B.A. | President, CEO & Director |
| Dr. Adam Gazzaley M.D., Ph.D. | Co-Founder, Chief Science Advisor & Director |
| Ms. Jacqueline L. Studer J.D. | Chief Legal Officer, General Counsel & Secretary |
| Ms. Caty Reid | VP of Marketing & Communications |
| Dr. Scott H. Kollins Ph.D. | Chief Medical Officer |
| Mr. Jonathan David | Chief Product Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.353 |
| Price-to-Sales TTM: | 12.314 |
| IPO Date: | 2022-08-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 68 |